Westfield, NJ, United States of America

George G Hazen

This inventor holds 8 USPTO granted patents. Top assignee: Merck + Co., Inc.. Active years: 1976-1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: George G Hazen. Retrieved from https://idiyas.com/inventor/george-g-hazen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 29(Granted Patents)


Location History:

  • Westfield, NJ (US) (1976 - 1984)
  • Perth Amboy, NJ (US) (1986 - 1991)

Company Filing History:


Years Active: 1976-1991

Loading Chart...
8 patents (USPTO):Explore Patents

Title: **The Innovative Journey of George G. Hazen**

Introduction

George G. Hazen is a distinguished inventor based in Westfield, NJ, with a remarkable portfolio of 8 patents. His contributions to the field of chemistry, particularly in the development of antibiotic synthesis processes, have marked significant advancements in pharmaceutical innovation. Working for Merck & Company, Inc., Hazen has played a vital role in creating important chemical intermediates.

Latest Patents

Hazen's recent work includes two notable patents. The first is a patent for a cyclization process for the synthesis of a beta-lactam carbapenem. This process focuses on the synthesis of 3(S)-4(R)-3-[1(S)-hydroxyethyl]-4-(alkoxycarbonylmethyl)-azetidin-2-one, a key intermediate in the production of carbapenem antibiotics. The second patent revolves around a novel process for preparing α-(trichloromethyl)benzyl alcohols, particularly the synthesis of trichloromethyl-3-nitrobenzyl alcohol. This compound serves as a critical intermediate in the preparation of clorsulon, which involves a base-catalyzed condensation reaction of benzaldehydes and chloroform.

Career Highlights

Throughout his career, George G. Hazen has established himself as a key figure in pharmaceutical research and development. His expertise in synthesis processes is a significant asset to Merck & Company, Inc., where he has developed methodologies that enhance the efficiency and effectiveness of drug development.

Collaborations

In his innovative journey, Hazen has collaborated with esteemed colleagues such as Ralph P. Volante and Earl M. Chamberlin. Their collective efforts have further propelled advancements in their field, fostering a collaborative environment that encourages groundbreaking innovations in chemistry.

Conclusion

George G. Hazen's contributions to the field of pharmaceutical sciences are noteworthy and continue to impact the development of vital medications. With his extensive patent portfolio and collaborative spirit, he exemplifies the innovative drive within the industry, inspiring future inventors to pursue advances in science and technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…